NCT02107339View on ClinicalTrials.gov

Methadone and Hydromorphone For Spinal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2017

Conditions
Hydromorphone UseAcute Postoperative PainPatient SatisfactionChronic Persistent Surgical Pain
Interventions
DRUG

Methadone

Methadone 0.2 mg/kg administered at induction of anesthesia

DRUG

Hydromorphone

Hydromorphone 2 mg administered at the conclusion of anesthesia

Trial Locations (1)

60201

NorthShore University HealthSystem, Evanston

Sponsors

Lead Sponsor

Endeavor Health
All Listed Sponsors
lead

Endeavor Health

OTHER

NCT02107339 - Methadone and Hydromorphone For Spinal Surgery | Biotech Hunter | Biotech Hunter